Automating QA in Neuro Trials, Shifting to FSP Outsourcing, and More
Clinical Leader
A resource and forum to investigate and resolve the common struggles related to running effective clinical trials.
Welcome to the Clinical Trial Insights newsletter, featuring strategic insights and expert opinions on designing and running clinical trials. Each edition covers the latest trending articles on ClinicalLeader.com .
In this week's issue we'll review the impact of automating quality assurance in neurology trials using speech analytics, why the industry is shifting to FSP outsourcing, how the Good Trials Prism is enhancing the quality of clinical research in LMICs, tips to reduce risk when migrating a trial master file, and other popular insights.
If you like what you're seeing in our condensed LinkedIn editions, subscribe to our daily newsletter for full access to exclusive articles, webinars, e-books, and more! Subscribe Now →
TOP 5 READS OF THE PAST WEEK
By automating quality assurance (QA) in clinical trials with speech analysis, sponsors can improve trial data and avoid the high cost and variable dependability of using specialized raters for clinical assessments in neurology. In this article, Celia Fidalgo, PhD and John Harrison discuss the integration and impact of automated quality assurance (AQUA).
While we are all familiar with full-service outsourcing, this report by PPD will delve into outsourcing specific functions and adhering to clients' standard operating procedures and systems through a functional service partnership (FSP), which has gained prominence due to recent industry challenges.
Guided by the five scientific and ethical principles described in the The Good Clinical Trials Collaborative 's Guidance for Good RCTs, learn how the Good Trials Prism aims to enhance the quality of clinical research in low and middle income countries including Latin America, Southeast Asia, and South Africa by prioritizing collaborative, informative, and efficient research responses to pressing public health issues.
Migrating Trial Master File (TMF) data is a fairly common occurrence, but it can be fraught with risk. Utilize Phlexglobal, A PharmaLex Company 's summary of key tips, checklists, and lessons learned to mitigate the risks and efforts associated with migrating a TMF.
领英推荐
What if we had integrated systems to direct patients into trials and achieved successful healthcare integration (HI) between healthcare and clinical research industries? Daniel Fox, MPH, PhD lays out how HI can change the clinical research ecosystem, why the industry has been slow to adopt it, and what the future of healthcare integration could like.
MORE TO EXPLORE
Join The Only Online Community Focused On Clinical Supply Chain & Logistics!
Clinical Supply Leader is focused on helping you pinpoint inefficiencies in your clinical trial supply chain and identify effective and compliant solutions.
Subscribe to the Clinical Supply Leader newsletter to receive weekly insights on best practices, new solutions, and top suppliers that can help you tackle your supply chain challenges.
Clinical Leader is an online community serving professionals in the clinical research space. We share insights and best practices — from industry experts — to help sponsors and CROs tackle the biggest challenges they face in designing and running clinical trials.
To get the most out of our offerings, join the Clinical Leader community .